clopidogrel

Latest stories

3d
News-Medical-Net
Administering ticagrelor in the ambulance cuts ischaemic events 24 hours following PCITicagrelor administered in the ambulance reduces ischaemic events 24 hours afte
Administering ticagrelor in the ambulance cuts ischaemic events 24 hours following PCI
News-Medical-Net / Posted 3 days ago
Ticagrelor administered in the ambulance reduces ischaemic events 24 hours after primary percutaneous coronary intervention (PCI), according to findings from the ATLANTIC-H24 study presented for the first time today at ESC Congress. The ATLANTIC2... Read more
11d
Business Wire
Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE
Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015
Business Wire / Posted 11 days ago
PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) announced today that 22 abstracts (late-breaking, rapid-fire, oral and poster presentations) will be presented at the ESC Congress 2015,... Read more
11d
Business Wire
The Medicines Company Announces Participation at 2015 European Society of Cardiology (ESC) Congress in LondonPARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company today announced it wil
The Medicines Company Announces Participation at 2015 European Society of Cardiology (ESC) Congress in London
Business Wire / Posted 11 days ago
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company today announced it will present results of recent clinical studies from its cardiovascular product portfolio at the 2015 European Society of Cardiology (ESC) Congress in London, August 29 to... Read more
22d
News-Medical-Net
ESC Congress to highlight results from global trials in six press conferencesMembers of the press will be the first to hear the highly anticipated results f
ESC Congress to highlight results from global trials in six press conferences
News-Medical-Net / Posted 22 days ago
Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research: Coronary artery disease: the outcomes of an FFRCT diagnostic strategy versus usual care in... Read more
25d
The Manteca Bulletin
More frequent, higher doses of nsaids carry greater risk of side effectsDEAR DR. ROACH: I am a 44-year-old man with chronic headaches and migraines. Sh
More frequent, higher doses of nsaids carry greater risk of side effects
The Manteca Bulletin / Posted 25 days ago
DEAR DR. ROACH: I am a 44-year-old man with chronic headaches and migraines. Should I worry about the long-term effects of taking an NSAID (such as diclofenac) at least once a week? -- G.W. ANSWER: Nonsteroidal anti-inflammatory drugs are among the... Read more
25d
The Advertiser-Tribune
Frequent doses of NSAIDs increase risksAnswer: Nonsteroidal anti-inflammatory drugs are among the most commonly taken
Frequent doses of NSAIDs increase risks
The Advertiser-Tribune / Posted 25 days ago
Answer: Nonsteroidal anti-inflammatory drugs are among the most commonly taken classes of drugs in the world, with 17 million Americans alone taking them daily. Although these drugs are generally safe, any medication has the potential for side... Read more
30d
Medical News Today
What is a heart attack? What causes a heart attack?Heart attack is the death of a segment of heart muscle caused by the loss of bl
What is a heart attack? What causes a heart attack?
Medical News Today / Posted 30 days ago
Heart attack is the death of a segment of heart muscle caused by the loss of blood supply. The blood supply is usually lost because a coronary artery, one that supplies blood to the heart muscle, has a blood clot, a blockage (coronary thrombosis). If... Read more
5 related stories

People in this news